Trial
NCT00253318
RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
M.D. Anderson Cancer Center
Collaborators
Novartis Pharmaceuticals
Condition
Breast Cancer
Intervention
Docetaxel
Why stopped
Toxicity and Lack of Efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-18